Advertisement

Genitourinary

  • Nicole LarrierEmail author
Part of the Pediatric Oncology book series (PEDIATRICO)

Abstract

This chapter addresses the long-term effects of the treatment of childhood cancer on the genitourinary (GU) tract, primarily focusing on the kidneys, ureters, bladder, urethra, prostate, vagina, and uterus. The effects on ovaries and testes are reviewed in Chaps.  13 and  14. The most common pediatric cancers that occur in the GU tract include Wilms’ tumor, neuroblastoma, and rhabdomyosarcoma. The median age of children affected with these tumors ranges from 3 years (Wilms’ tumor, neuroblastoma) to 6 years (rhabdomyosarcoma). Growth and development of the GU tract in the following years may be compromised by the cancer treatment, including surgery, radiation therapy (RT), or chemotherapy; see Table 15.1. Recent changes in cancer therapy, including bone marrow transplantation, intraoperative radiation therapy, and high-dose rate brachytherapy, pose new risks that have not been clearly defined. Furthermore, GU organs may be incidentally damaged by therapies used to treat tumors in non-GU organs. For example, many of the chemotherapeutic agents used to treat both GU and non-GU tumors are potentially toxic to the kidney and/or bladder. In addition, radiation fields designed to treat the liver or pelvic bones usually include portions of the kidney or bladder.

Keywords

Glomerular Filtration Rate Childhood Cancer Transitional Cell Carcinoma Urinary Diversion Hemorrhagic Cystitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

The author wishes to acknowledge L. Marks, B. Raney, R. Heyn, and R. Cassaday.

References

  1. 1.
    Schmidt A (1992) Long term results after partial and unilateral nephrectomy in childhood. Eur J Pediatr Surg 2:269–273CrossRefPubMedGoogle Scholar
  2. 2.
    Raney B et al (1993) Sequelae of treatment of 109 patients followed for five to fifteen years after diagnosis of sarcoma of the bladder and prostate: a report from the Intergroup Rhabdomyosarcoma Study (IRS Committee). Cancer 71:2387–2394CrossRefPubMedGoogle Scholar
  3. 3.
    Wespes E, Stone AF, King LR (1986) Ileocaecocystoplasty in urinary tract reconstruction in children. Br J Urol 58:266–272CrossRefPubMedGoogle Scholar
  4. 4.
    Filmer RB, Spencer JR (1990) Malignancies in bladder augmentations and intestinal conduits. J Urol 122:163–164Google Scholar
  5. 5.
    Gitlin J et al (1999) New concepts of histological changes in experimental augmentation cystoplasty. Urology 162:1096–1100CrossRefGoogle Scholar
  6. 6.
    Golomb J, Klutke CG, Raz S (1989) Complications of bladder substitution and continent urinary diversion. Urology 34:329–338CrossRefPubMedGoogle Scholar
  7. 7.
    Meadows AT et al (1985) Second malignant neoplasms in children: an update from the late effects study group. J Clin Oncol 3:532–538PubMedGoogle Scholar
  8. 8.
    Cassady JR (1995) Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys 31:1249–1256CrossRefPubMedGoogle Scholar
  9. 9.
    Marks LB et al (1995) The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 31:1257–1280CrossRefPubMedGoogle Scholar
  10. 10.
    Stewart FA (1986) Mechanism of bladder damage and repair after treatment with radiation and cytostatic drugs. Br J Cancer 53:280–291CrossRefGoogle Scholar
  11. 11.
    Suresh UR et al (1993) Radiation disease of the urinary tract: histological features of 18 cases. J Clin Pathol 46:228–231PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Dewit L, Ang KK, Vanderschueren E (1983) Acute side effects and late complications after radiotherapy of localized carcinoma of the prostate. Cancer Treat Rep 10:79–89CrossRefGoogle Scholar
  13. 13.
    Montana GS, Fowler WC (1989) Carcinoma of the cervix: analysis of bladder and rectal radiation dose and complications. Int J Radiat Oncol Biol Phys 16:95–100CrossRefPubMedGoogle Scholar
  14. 14.
    Perez CA et al (1984) Radiation therapy alone in the treatment in the treatment of carcinoma of the uterine cervix II. Analysis of complications. Cancer 54:235–246CrossRefPubMedGoogle Scholar
  15. 15.
    Perez CA et al (1986) Radiation therapy alone in the treatment of carcinoma of the uterine cervix: a 20-year experience. Gynecol Oncol 23:127–140CrossRefPubMedGoogle Scholar
  16. 16.
    Pourquier H et al (1987) A quantified approach to the analysis and prevention of urinary complications in radiotherapeutic treatment of cancer of the cervix. Int J Radiat Oncol Biol Phys 12:1025–1033CrossRefGoogle Scholar
  17. 17.
    Ryu JK et al (2002) Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer 3dOG/RTOG 9406, level III (79.2 Gy). Int J Radiat Oncol Biol Phys 54:1036–1046CrossRefPubMedGoogle Scholar
  18. 18.
    Buglione M et al (2002) Post-radiation pelvic disease and ureteral stenosis: pathophysiology and evolution in the patient treated for cervical carcinoma. Review of the literature and experience of the Radium Institute. Arch Ital Urol Androl 71:6–11Google Scholar
  19. 19.
    Kontturi M, Kauppila A (1982) Ureteric complications following treatment of gynaecological cancer. Ann Chir Gynaecol 71:232–238PubMedGoogle Scholar
  20. 20.
    Abitol MM, Davenport JH (1974) The irradiated vagina. Obstet Gynecol 44:249–256Google Scholar
  21. 21.
    Kapoor M, Chan G (2001) Malignancy and renal disease. Crit Care Chirurgy 17(3):571–598CrossRefGoogle Scholar
  22. 22.
    Stewart DJ et al (1985) Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose and nephrotoxicity. J Clin Oncol 3:1251–1256PubMedGoogle Scholar
  23. 23.
    Brock PR et al (1991) Partial reversibility of cisplatin nephrotoxicity in children. J Pediatr 118:531CrossRefPubMedGoogle Scholar
  24. 24.
    Crom WR et al (1984) The effect of prior cisplatin therapy on the pharmacokinetics of high-dose methotrexate. J Clin Oncol 2:655–661PubMedGoogle Scholar
  25. 25.
    Grigg A et al (1996) Multi-organ dysfunction associated with high-dose carboplatin therapy prior to autologous transplantation. Bone Marrow Transplant 17(1):67–74PubMedGoogle Scholar
  26. 26.
    Petrilli AS et al (2002) Use of amifostine in the therapy of osteosarcoma in children and adolescents. J Pediatr Hematol Oncol 24:188–191CrossRefPubMedGoogle Scholar
  27. 27.
    Renner S et al (2000) Effect of amifostine on neuroblastoma during high dose chemotherapy: in vivo and in vitro investigations. Anticancer Res 20:4531–4538PubMedGoogle Scholar
  28. 28.
    Marina N et al (2005) Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children’s Oncology Group study. Cancer 104(4):841–847CrossRefPubMedGoogle Scholar
  29. 29.
    Skinner R et al (1996) Risk factors for ifosfamide nephrotoxicity in children with cancer. Lancet 348(80):578CrossRefPubMedGoogle Scholar
  30. 30.
    Skinner R et al (1990) Nephrotoxicity after ifosfamide. Arch Dis Child 65:732–738PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Vogelzang NJ (1991) Nephrotoxicity from chemotherapy: prevention and management. Oncology 5:97–112PubMedGoogle Scholar
  32. 32.
    Prasad et al (1996) Progressive glomerular toxicity of ifosfamide in children. Med Pediatr Oncol 27:149CrossRefPubMedGoogle Scholar
  33. 33.
    Skinner R, Cotterill SK, Stevens MC (2000) Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG late effects group study. Br J Cancer 82:1636–1645PubMedCentralCrossRefPubMedGoogle Scholar
  34. 34.
    Raney B et al (1992) Renal toxicity in patients treated with ifosfamide in intergroup rhabdomyosarcoma study (IRS)IV pilot regimens. Med Pediatr Oncol 20:429Google Scholar
  35. 35.
    Hempel L (2003) Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function. Med Pediatr Oncol 40:348–354CrossRefPubMedGoogle Scholar
  36. 36.
    Levine LA, Richie JP (1989) Urological complications of cyclophosphamide. J Urol 141:1063–1069PubMedGoogle Scholar
  37. 37.
    Sarosy G (1989) Ifosfamide pharmacologic overview. Semin Oncol 16:2–8PubMedGoogle Scholar
  38. 38.
    Sklar CA, LaQuaglia MP (2000) The long term complications of chemotherapy in childhood genitourinary tumors. Urol Clin North Am 27:563–568CrossRefPubMedGoogle Scholar
  39. 39.
    Samra Y, Hertz M, Lindner A (1985) Urinary bladder tumors following cyclophosphamide therapy: a report of two cases with a review of the literature. Med Pediatr Oncol 12:86–91CrossRefGoogle Scholar
  40. 40.
    Tefft M et al (1976) Acute and later effects on normal tissues following combined chemo-and radiotherapy for childhood rhabdomyosarcoma and Ewing’s sarcoma. Cancer 37:1201–1213CrossRefPubMedGoogle Scholar
  41. 41.
    Tarbell NJ et al (1990) Renal insufficiency after total body irradiation for pediatric bone marrow transplantation. Radiother Oncol 18(Supp i):i39–i4239Google Scholar
  42. 42.
    Guinan EC et al (1988) Intravascular hemolysis and renal insufficiency after bone marrow transplantation. J Clin Oncol 72:451–455Google Scholar
  43. 43.
    Gronroos MH et al (2007) Long-term renal function following bone marrow transplantation. Bone Marrow Transplant 39(11):717–723CrossRefPubMedGoogle Scholar
  44. 44.
    Vogeli TA (1999) Urological treatment and clinical course of BK polyomavirus-associated hemorrhagic cystitis in children after bone marrow transplantation. Eur Urol 36:252–257CrossRefPubMedGoogle Scholar
  45. 45.
    Walker RD et al (1982) Compensatory renal growth and function in post-nephrectomized patients with Wilms’ tumor. Urology 19:127CrossRefPubMedGoogle Scholar
  46. 46.
    Wikstad I et al (1986) A comparative study of size and function of the remnant kidney in patients nephrectomized in childhood for Wilms’ tumor and hydronephrosis. Acta Paediatr Scand 5:408CrossRefGoogle Scholar
  47. 47.
    Luttenegger TJ et al (1975) Compensatory renal hypertrophy after treatment for Wilms’ tumor. Am J Roentgenol 125:348CrossRefGoogle Scholar
  48. 48.
    Cassidy MJD, Beck RM (1988) Renal functional reserve in live related kidney donors. Am J Kidney Dis 11:468–472CrossRefPubMedGoogle Scholar
  49. 49.
    Cassidy JR et al (1981) Effect of low dose irradiation on renal enlargement in children following nephrectomy for Wilms’ tumor. Acta Radiol Oncol 20:5–8CrossRefGoogle Scholar
  50. 50.
    Vaeth JM (1964) The remaining kidney in irradiated survivors of Wilms’ tumor. Am J Roentgenol 92:148Google Scholar
  51. 51.
    Hale GA et al (1999) Late effects of treatment for germ cell tumors during childhood and adolescence. J Pediatr Hematol Oncol 21:115–122CrossRefPubMedGoogle Scholar
  52. 52.
    Bolling T et al (2011) Dose-volume analysis of radiation nephropathy in children: preliminary report of the risk consortium. Int J Radiat Oncol Biol Phys 80(3):840–844CrossRefPubMedGoogle Scholar
  53. 53.
    Pai Panandiker AS et al (2012) Novel assessment of renal motion in children as measured via four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 82(5):1771–1776CrossRefPubMedGoogle Scholar
  54. 54.
    Nazmy MS et al (2012) Cone beam CT for organs motion evaluation in pediatric abdominal neuroblastoma. Radiother Oncol 102(3):388–392CrossRefPubMedGoogle Scholar
  55. 55.
    Oberlin O et al (2009) Long-term evaluation of Ifosfamide-related nephrotoxicity in children. J Clin Oncol 27(32):5350–5355CrossRefPubMedGoogle Scholar
  56. 56.
    Gill WB et al (1980) Sandwich radiotherapy (3000 and 4500 rads) around radical retropubic prostatectomy for stage C prostatic carcinoma. Urology 16:470–475CrossRefPubMedGoogle Scholar
  57. 57.
    El-Mahdi AM et al (1974) Sequelae of pelvic irradiation in infancy. Radiology 110:665–666CrossRefPubMedGoogle Scholar
  58. 58.
    Flamant F et al (1979) Embryonal rhabdomyosarcoma of the vagina in children. Conservative treatment with curietherapy and chemotherapy. Eur J Cancer 15:527–532CrossRefPubMedGoogle Scholar
  59. 59.
    Flamant F et al (1990) Long-term sequelae of conservative treatment for vulvar and vaginal rhabdomyosarcoma in children. J Clin 8:1847–1853Google Scholar
  60. 60.
    Rotman M, Aziz H, Choi KN (1989) Radiation damage of normal tissues in the treatment of gynecologic cancers. In: Vaeth JM, Meyer JL (eds) Frontiers of radiation therapy and oncology, vol 23, Radiation tolerance of normal tissues. Karger, BaselGoogle Scholar
  61. 61.
    Grigsby PW et al (1995) Late injury of cancer therapy on the female reproductive tract. Int J Radiat Oncol Biol Phys 31:1281–1299CrossRefPubMedGoogle Scholar
  62. 62.
    Li FP et al (1987) Outcome of pregnancies in survivors of Wilms’ tumor. JAMA 257:216–219CrossRefPubMedGoogle Scholar
  63. 63.
    Piver MS, Rose PG (1988) Long-term follow-up and complications of infants with vulvovaginal embryonal rhabdomyosarcoma treated with surgery, radiation therapy and chemotherapy. Obstet Gynecol 71:435–437PubMedGoogle Scholar
  64. 64.
    Kalapurakal JA et al (2004) Pregnancy outcomes after abdominal irradiation that included or excluded the pelvis in childhood Wilms tumor survivors: a report from the National Wilms Tumor Study. Int J Radiat Oncol Biol Phys 58(5):1364–1368CrossRefPubMedGoogle Scholar
  65. 65.
    Gronroos ML et al (1996) Renal failure in Wilms’ tumor patients: a report from the National Wilms’ Tumor Study Group. Med Pediatr Oncol 26:75–80CrossRefGoogle Scholar
  66. 66.
    Ritchey ML et al (1990) Pediatric urological complications with intraoperative radiation therapy. J Urol 143(1):89–91PubMedGoogle Scholar
  67. 67.
    Langer T et al (2000) Basic method and the developing structure of a late effects surveillance system (LESS) in the long-term follow up of pediatric cancer patients in Germany. Med Pediatr Oncol 34:348–351CrossRefPubMedGoogle Scholar
  68. 68.
    Oeffinger KC et al (2000) Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. Cancer 88:1687–1695CrossRefPubMedGoogle Scholar
  69. 69.
    Schwartz CL (1999) Long-term survivors of childhood cancer: the late effects of therapy. Oncologist 4:45–54PubMedGoogle Scholar
  70. 70.
    Cronan JJ et al (1989) Antibiotics and nephrostomy tube care: preliminary observations, part II. Bacteremia. Radiology 172:1043–1045CrossRefPubMedGoogle Scholar
  71. 71.
    Wood DP et al (2003) Incidence and significance of positive urine culture in patients with an orthotopic neobladder. J Urol 169:2196–2199CrossRefPubMedGoogle Scholar
  72. 72.
    Dewan AK, Mohan GM, Ravi R (1996) Intravesical formalin for hemorrhagic cystitis following irradiation of cancer of the cervix. Int J Gynaecol Obstet 42:131CrossRefGoogle Scholar
  73. 73.
    Corman JM et al (2003) Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol 169:2200–2202CrossRefPubMedGoogle Scholar
  74. 74.
    Kadan-Lottick NS et al (2002) Childhood survivors’ knowledge about their past diagnosis and treatment: childhood cancer survivor study. JAMA 287:1832–1839CrossRefPubMedGoogle Scholar
  75. 75.
    Barrera RLP, Stevens M (1989) Long-term follow-up after unilateral nephrectomy and radiotherapy for Wilms’ tumor. Pediatr Nephrol 3:430–432CrossRefPubMedGoogle Scholar
  76. 76.
    Heyn R et al (1992) Late effects of therapy in patients with paratesticular rhabdomyosarcoma. J Clin Oncol 10:614–623PubMedGoogle Scholar
  77. 77.
    Jaffe N (1987) Renal toxicity with cumulative doses of cis-diamminedichloroplatinum-II in pediatric patients with osteosarcoma. Effect on creatinine clearance and methotrexate excretion. Cancer 59:1577–1581CrossRefPubMedGoogle Scholar
  78. 78.
    Makipernaa A et al (1991) Renal growth and function 11–28 years after treatment for Wilms’ tumors. Eur J Pediatr 150:444–447CrossRefPubMedGoogle Scholar
  79. 79.
    Ritchey ML et al (1996) Renal failure in Wilms’ tumor patients: a report from the National Wilms’ Tumor Study Group. Med Pediatr Oncol 26(2):75–80CrossRefPubMedGoogle Scholar
  80. 80.
    Paulino AC et al (2000) Late effects in children treated with radiation therapy for Wilms’ tumor. Int J Radiat Oncol Biol Phys 46:1239–1246CrossRefPubMedGoogle Scholar
  81. 81.
    Stea B et al (1987) Treatment of pelvic sarcomas in adolescents and young adults with intensive combined modality therapy. Int J Radiat Oncol Biol Phys 13:1797–1805CrossRefPubMedGoogle Scholar
  82. 82.
    Thomas PRM et al (1983) Late effects of treatment for Wilms’ tumor. Int J Radiat Oncol Biol Phys 9:651–657CrossRefPubMedGoogle Scholar
  83. 83.
    Tarbell NJ et al (1990) Renal insufficiency after total body irradiation for pediatric bone marrow transplantation. Radiother Oncol 18(Suppl 1):139–142CrossRefPubMedGoogle Scholar
  84. 84.
    Esiashvili N et al (2009) Renal toxicity in children undergoing total body irradiation for bone marrow transplant. Radiother Oncol 90(2):242–246CrossRefPubMedGoogle Scholar
  85. 85.
    Guinan EC et al (1988) Intravascular hemolysis and renal insufficiency after bone marrow transplantation. Blood 72(2):451–455PubMedGoogle Scholar

Copyright information

© Springer International Publishing 2015

Authors and Affiliations

  1. 1.Department of Radiation OncologyDuke University Medical CenterDurhamUSA

Personalised recommendations